3D Bioprinting at the Frontier of Regenerative Medicine, Pharmaceutical, and Food Industries

3D printing technology has emerged as a key driver behind an ongoing paradigm shift in the production process of various industrial domains. The integration of 3D printing into tissue engineering, by utilizing life cells which are encapsulated in specific natural or synthetic biomaterials (e.g., hyd...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in medical technology Vol. 2; p. 607648
Main Authors Ramadan, Qasem, Zourob, Mohammed
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 28.01.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:3D printing technology has emerged as a key driver behind an ongoing paradigm shift in the production process of various industrial domains. The integration of 3D printing into tissue engineering, by utilizing life cells which are encapsulated in specific natural or synthetic biomaterials (e.g., hydrogels) as bioinks, is paving the way toward devising many innovating solutions for key biomedical and healthcare challenges and heralds' new frontiers in medicine, pharmaceutical, and food industries. Here, we present a synthesis of the available 3D bioprinting technology from what is found and what has been achieved in various applications and discussed the capabilities and limitations encountered in this technology.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Reviewed by: Sasan Jalili-Firoozinezhad, Koch Institute for Integrative Cancer Research at MIT, United States; Elena Pirogova, RMIT University, Australia
This article was submitted to Pharmaceutical Innovation, a section of the journal Frontiers in Medical Technology
Edited by: Khashayar Khoshmanesh, RMIT University, Australia
ISSN:2673-3129
2673-3129
DOI:10.3389/fmedt.2020.607648